Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic partial agonists, including cytisine, which is not yet available in this country, and varenicline, which is.

Original publication

DOI

10.3132/pccj.2009.019

Type

Journal article

Journal

Primary Care Cardiovascular Journal

Publication Date

01/04/2009

Volume

2

Pages

87 - 89